Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature Medicine 8, 738 - 742 (2002)
Published online: 17 June 2002 | doi:10.1038/nm727
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Kazumasa Miyawaki1,6, Yuichiro Yamada1,6, Nobuhiro Ban1, Yu Ihara1, Katsushi Tsukiyama1, Heying Zhou1, Shimpei Fujimoto1, Akira Oku1, Kinsuke Tsuda1, Shinya Toyokuni2, Hiroshi Hiai2, Wataru Mizunoya3, Tohru Fushiki3, Jens Juul Holst4, Mitsuhiro Makino5, Akira Tashita5, Yukari Kobara5, Yoshiharu Tsubamoto5, Takayoshi Jinnouchi5, Takahito Jomori5 & Yutaka Seino1
Abstract
Secretion of gastric inhibitory polypeptide (GIP), a duodenal hormone, is primarily induced by absorption of ingested fat. Here we describe a novel pathway of obesity promotion via GIP. Wild-type mice fed a high-fat diet exhibited both hypersecretion of GIP and extreme visceral and subcutaneous fat deposition with insulin resistance. In contrast, mice lacking the GIP receptor (Gipr-/-) fed a high-fat diet were clearly protected from both the obesity and the insulin resistance. Moreover, double-homozygous mice (Gipr-/-, Lepob/Lepob) generated by crossbreeding Gipr-/- and obese ob/ob (Lepob/Lepob) mice gained less weight and had lower adiposity than Lepob/Lepob mice. The Gipr-/- mice had a lower respiratory quotient and used fat as the preferred energy substrate, and were thus resistant to obesity. Therefore, GIP directly links overnutrition to obesity and it is a potential target for anti-obesity drugs.
To read this story in full you will need to login or make a payment (see right).
